Affiliation:
1. Mechnikov North-Western State Medical University named
Abstract
Patients with embolic myocardial infarction (MI) represent a high-risk group and, accordingly, require special attention of clinicians. This article discusses the most common causes of MI, related diagnostic criteria, antithrombotic therapy, and myocardial revascularization in this category of patients. The data of own clinical experience are also given.
Subject
Cardiology and Cardiovascular Medicine
Reference27 articles.
1. Sulimov VA, Golicin SP, Panchenko EP, et al. 2012 Guideline on diagnostic and management of atrial fibrillation. Russian Journal of Cardiology. 2013;(4),S3:5-100. (In Russ.) Сулимов В.А., Голицын С.П., Панченко Е.П. и др. 2012 doi:10.15829/1560-4071-2013-4s3-5-100.
2. Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines on management of atrial fibrillation. Russian Journal of Cardiology. 2017;(7):7-86. (In Russ.) doi:10.15829/1560-4071-2017-7-7-86.
3. Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2013;174(1):107- 14. doi:10.1001/jamainternmed.2013.11912.
4. Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30:1038- 45. doi:10.1093/eurheartj/ehn579.
5. Patricia J, Jouven X, Adnet F, et al. Atrial fibrillation and death after myocardial infarction. A community study. Circulation. 2011;123:2094-100. doi:10.1161/CIRCULATIONAHA.110.990192.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献